Provides for the prohibition of marketing to minors for medical products, procedures, and pharmaceuticals from state agencies (OR SEE FISC NOTE FF EX See Note)
Requires the Louisiana Department of Health to annually review medications, forms of treatment, and services for care of Medicaid enrollees with sickle cell disease. (8/1/22)
Restricts prescribing and dispensing of certain drugs to delay puberty and prohibits withholding of certain information from the minor's parent or legal guardian (OR SEE FISC NOTE GF EX)
Provides for payment enhancements to compensate nonemergency medical transportation providers for cost increases in that industry (EG1 +$1,045,080 GF EX See Note)